TL;DR
Most wrinkle creams try to cover lines up or plump them for a few hours. Azitra is betting on something more basic: putting back filaggrin, the protein that helps build skin's outer barrier and hold in moisture, and that many people lack or lose. The company says a lab-made version, called ATR-COSF, cut wrinkles 56% from where they started in human skin kept alive outside the body, and improved elasticity within 48 hours compared with a plain cream. That is a company claim from human skin kept alive in the lab, not from people, and the company says a first human study is next, with initial results expected by the end of 2026. If it carries over, repairing the skin barrier and smoothing fine lines could turn out to be the same job. Our odds on when a barrier-protein cream proves itself on real faces, and the timeline of skin-rejuvenation breakthroughs around it, are below the line: subscribe to see them.
Below the line, for paid subscribers: The full story: where it stands, how we got here and what's dated next; our labeled speculation on what it adds up to; and every source.